Portal vein thrombosis and non-compliance in a high risk patient – a case study
DOI:
https://doi.org/10.12775/JEHS.2022.12.06.027Keywords
portal vein thrombosis, polycythemia vera, splenectomy, SARS-CoV-2, non-complianceAbstract
Portal vein thrombosis is a pathological process that refers to the obstruction of blood flow secondary to thrombus formation. It may be caused by a variety of conditions including cancer, cirrhosis, myeloproliferative neoplasms (eg. polycythemia vera) or surgery in the area of the portal vein (eg. splenectomy). Recent studies suggest that patients with a positive history of SARS-CoV-2 infection have a higher risk of thromboembolic incidents. According to current procedures patients with increased thromboembolic risk should receive anticoagulants. Non-compliance to medical recommendations may develop a disease, directly threatening the patient's health and life. We present a case report of a 69 year old woman with a history of polycythemia vera, recent splenectomy, and SARS-CoV-2 infection who developed massive portal vein thrombosis two days after discontinuation of enoxaparin.
References
Bayraktar Y, Harmanci O. Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol. 2006 Feb 28;12(8):1165-74. doi: 10.3748/wjg.v12.i8.1165. PMID: 16534866; PMCID: PMC4124424.
Haris M, Thachil J. Portal vein thrombosis - a primer for the general physician. Clin Med (Lond). 2017 Jun;17(3):212-219. doi: 10.7861/clinmedicine.17-3-212. Erratum in: Clin Med (Lond). 2017 Jul;17 (4):347. Harris M [corrected to Haris M]. PMID: 28572222; PMCID: PMC6297567.
Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol. 2006 Apr 7;12(13):2115-9. doi: 10.3748/wjg.v12.i13.2115. PMID: 16610067; PMCID: PMC4087695.
Stuart BJ, Viera AJ. Polycythemia vera. Am Fam Physician. 2004 May 1;69(9):2139-44. PMID: 15152961.
van't Riet M, Burger JW, van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg. 2000 Sep;87(9):1229-33. doi: 10.1046/j.1365-2168.2000.01514.x. PMID: 10971433.
Fujita F, Lyass S, Otsuka K, Giordano L, Rosenbaum DL, Khalili TM, Phillips EH. Portal vein thrombosis following splenectomy: identification of risk factors. Am Surg. 2003 Nov;69(11):951-6. PMID: 14627254.
Franco-Moreno A, Piniella-Ruiz E, Montoya-Adarraga J, Ballano-Franco C, Alvarez-Miguel F, Peinado-Martinez C, Landete-Hernandez E, Saez-Vaquero T, Ulla-Anes M, Torres-Macho J. Portal vein thrombosis in a patient with COVID-19. Thromb Res. 2020 Oct;194:150-152. doi: 10.1016/j.thromres.2020.06.019. Epub 2020 Jun 13. PMID: 32788107; PMCID: PMC7293484.
Rehman A, Thoppil AJ, Wallach SL. Portal Vein Thrombosis and Splenic Infarction in a COVID-19 Patient. Cureus. 2021 Aug 2;13(8):e16843. doi: 10.7759/cureus.16843. PMID: 34513429; PMCID: PMC8410986.
Sogaard, K.K., Astrup, L.B., Vilstrup, H. et al. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol 7, 34 (2007). https://doi.org/10.1186/1471-230X-7-34
Dingli D, Tefferi A. Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia. Curr Hematol Malig Rep. 2006 Jun;1(2):69-74. doi: 10.1007/s11899-006-0025-4. PMID: 20425334.
Tefferi A, Elliott MA, Solberg LA Jr, Silverstein MN. New drugs in essential thrombocythemia and polycythemia vera. Blood Rev. 1997 Mar;11(1):1-7. doi: 10.1016/s0268-960x(97)90001-1. PMID: 9218101.
De Stefano V, Rossi E, Carobbio A, Ghirardi A, Betti S, Finazzi G, Vannucchi AM, Barbui T. Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases. Blood Cancer J. 2018 Nov 12;8(11):112. doi: 10.1038/s41408-018-0151-y. PMID: 30420642; PMCID: PMC6232117.
Gameiro AF, Robalo Nunes A, Guerra P, Mateus E, Fernandes F. Portal Vein Thrombosis Secondary to Occult Polycythemia Vera. Eur J Case Rep Intern Med. 2020 Nov 2;7(12):002003. doi: 10.12890/2020_002003. PMID: 33457359; PMCID: PMC7806286
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Aleksandra Marczak, Michalina Hordejuk, Jakub Gołacki, Klaudia Sapuła, Klaudyna Iwaszko-Sochal
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 415
Number of citations: 0